A Phase 1 Study to Evaluate the Immunologic Mechanisms Underlying Wart Resolution After Intralesional Immunotherapy With Candida Antigen.
Phase of Trial: Phase I
Latest Information Update: 24 Jan 2010
At a glance
- Drugs Candida antigen (Primary)
- Indications Warts
- Focus Therapeutic Use
- 22 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jun 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Dec 2007 New trial record.